Effects of aspirin on oxidative and nitrosative stress in vascular endothelial cell cultures

Year 2016, Volume: 33 Issue: 3, 129 - 137, 06.01.2017

Gunnur Demircan , Emine Diraman Yeliz Yilmaz Miroglu Sabri Demircan Zafer Yazici Ahmet Yilmaz Coban Tuba Yildirim Ayhan Bilir

Abstract

In this study, it was aimed to investigate that whether any change in activity of catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), lipid peroksidase and nitric oxide (NO) over time, and whether any difference between the different doses by giving different doses of aspirin to endothelial cells. Endothelial cells (HUVEC) in 24 wells microplates used in this study and 25, 50, 100, 250, 500, 750, 1000 and 1500 μM aspirin to 2 of 4 wells at each row were given, the other 2 wells were included as controls. Accordingly, while CAT, SOD, GSH-Px levels and lipid peroxidation were being measured, NO release from cell media was observed. The significant differences were not found between the baseline (0 hour) CAT, SOD, GSH-Px and lipid peroxidase levels measured from lisates that obtained from the cells that different drug doses given and controls (p>0.05). Also, CAT, SOD, GSH-Px and lipid peroxidase levels at 24 (p>0.05), 48 and 72 hours did not show any difference among different drug doses and control (p>0.05). In the control group significant differences were found between CAT, SOD and GSH-Px levels measured at 0, 24, 48, 72 hours (p<0.05, p<0.05 and p<0.05 respectively) but lipid peroxidase activity and NO levels showed no difference. Increase in antioxidant enzyme activity in the cells that aspirin was not given, caused by raised free radical formation due to increase in number of cells by time was observed. Aspirin prevented the increase in reactive enzyme activity which increases by time. These results suggest that nontoxic doses of aspirin might protect the cells.

Keywords

Aspirin, Cell celture, Endothelium, Nitrosative Stress, Oxidative Stress

References

• Antiplatelet Trialists Collaboration, Collaborative overview of randomised trials of antiplatelet therapy I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients, 1994. 308, 81-106.
• Bulckaen, H., Prévost, G., Boulanger, E., Robitaille, G., Roquet, V., Gaxatte, C., Garçon, G., Corman, B., Gosset, P., Shirali, P., Creusy, C., Puisieux, F., 2008. Low-dose aspirin prevents age-related endothelial dysfunction in a mouse model of physiological aging. Am. J. Physiol. Heart Circ. Physiol. 294, 1562-1570.
• Büssemaker, E., Pistrosch, F., Förster, S., Herbrig, K., Gross, P., Passauer, J., Brandes, R.P. 2007. Rho kinase contributes to basal vascular tone in humans: Role of endothelium-derived nitric oxide. Am. J. Physiol. Heart Circ. Physiol. 293, 541-547.
• Calver, A., Collier, J., Vallance, P., 1993. Nitric oxide and cardiovascular control. Exp. Physiol. 78, 303-326.
• Channon, K.M., Guzik, T.J., 2002. Mechanisms of superoxide production in human blood vessels: Relationship to endothelial dysfunction, clinical and genetic risk factors. Physiol. Pharmacol. 53, 515-524.
• Grosser, N., Schröder, H., 2003. Aspirin protects endothelial cells from oxidant damage via the nitric oxide-cGMP pathway. Arterioscler Thromb. Vasc. Biol. 23, 1345-1351.
• Hess, M.L., Krause, S., Kontos. H.A., 1983. Mediation of sarcoplasmic reticulum disruption in the ischemic myocardium: Proposed mechanism by the interaction of hydrogen ions and oxygen free radicals. Adv. Exp. Med. Biol. 161, 377-389.
• Hink, U., Li. H., Mollnau, H., Oelze, M., Matheis, E., Hartmann, M., Skatchkov, M., Thaiss, F., Stahl, R.A., Warnholtz, A., Meinertz, T., Griendling, K., Harrison, D.G., Forstermann, U., Munzel, T., 2001. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ. Res. 88, 14-22.
• Irani, K., 2000. Oxidant signaling in vascular cell growth, death, and survival: A review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ. Res. 87, 179-183.
• Jackson, M.J., Papa, S., Bolaños, J., Bruckdorfer, R., Carlsen, H., Elliott, R.M., Flier, J., Griffiths, H.R., Heales, S., Holst, B., Lorusso, M., Lund, E., Øivind Moskaug, J., Moser, U., Di Paola, M., Polidori, M.C., Signorile, A., Stahl, W., Viña-Ribes, J., Astley, S.B., 2002. Antioxidants, reactive oxygen and nitrogen species, gene induction and mitochondrial function. Mol. Aspects. Med. 23, 209-285.
• Kunsch, C., Medford, R.M., 1999. Oxidative stress as a regulator of gene expression in the vasculature. Circ. Res. 85, 753-766.
• Matés, J.M., Pérez-Gómez, C., Núñez de Castro, I., 1999. Antioxidant enzymes and human diseases. Clin. Biochem. 32, 595-603.
• Matés, J.M., Pérez-Gómez, C., Olalla, L., Segura, J.M., Blanca, M., 2000. Allergy to drugs: Antioxidant enzymic activities, lipid peroxidation and protein oxidative damage in human blood. Cell Biochem. Funct. 18, 77-84.
• McGahon, A.J., Martin, S.J., Bissonnette, R.P., Mahboubi, A., Shi, Y., Mogil, R.J., Nishioka, W.K., Green, D.R. 1995. The end of the (cell) line: Methods for the study of apoptosis in vitro. Methods Cell Biol. 46, 153-185.
• Mohazzab-H, K.M., Agarwal, R., Wolin, M.S., 1999. Influence of glutathione peroxidase on coronary artery responses to alterations in PO2 and H2O2. Am. J. Physiol. 276, 235-241.
• Nedeljkovic, Z.S., Gokce. N., Loscalzo, J., 2003. Mechanisms of oxidative stress and vascular dysfunction. Postgrad. Med. J. 79, 195-199.
• Podhaisky, H.P., Abate, A., Polte, T., Oberle, S., Schröder, H., 1997. Aspirin protects endothelial cells from oxidative stresspossible synergism with vitamin E. FEBS Lett. 417, 349-351.
• Singal, P.K., Beamish, R.E., Dhalla, N.S., 1983. Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. Adv. Exp. Med. Biol. 161, 391-401.
• Singal, P.K., Khaper, N., Palace, V., Kumar, D., 1998. The role of oxidative stress in the genesis of heart disease. Cardiovasc. Res. 40, 426-432.
• Singh, U., Jialal, I., 2006. Oxidative stress and atherosclerosis. Pathophysiology. 13, 129-142.
• Srivastava, S.K., Ansari, N.H., Liu, S., Izban, A., Das, B., Szabo, G., Bhatnagar, A., 1989. The effect of oxidants on biomembranes and cellular metabolism. Mol. Cell Biochem. 91, 149-157.
• Tabima, D.M., Frizzell, S., Gladwin, M.T., 2012. Reactive oxygen and nitrogen species in pulmonary hypertension. Free Radic. Biol. Med. 52, 1970-1986.
• Taubert, D., Berkels, R., Grosser, N., Schröder, H., Gründemann, D., Schömig, E., 2004. Aspirin induces nitric oxide release from vascular endothelium: A novel mechanism of action. Br. J. Pharmacol. 143, 159-165.
• Valko, M., Leibfritz, D., Moncol, J., Cronin M.T., Mazur, M., Telser, J., 2007. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39, 44-84.
• Vargaftig, B.B., 1978. The inhibition of cyclo-oxygenase of rabbit platelets by aspirin is prevented by salicylic acid and by phenanthrolines. Eur. J. Pharmacol. 50, 231-241.
• Varshney, R., Kale, R.K., 1990. Effects of calmodulin antagonists on radiation-induced lipid peroxidation in microsomes. Int J Radiat Biol. 58, 733-743.
• Vogiatzi, G., Tousoulis, D., Stefanadis, C., 2009. The role of oxidative stress in atherosclerosis. Hellenic. J. Cardiol. 50, 402-409.
• Watała, C., Gwoździński, K., 1993. Effect of aspirin on conformation and dynamics of membrane proteins in platelets and erythrocytes. Biochem. Pharmacol. 45, 1343-1349.
• Wolin, M.S., 1991 Activated oxygen metabolites as regulators of vascular tone. Klin. Wochenschr. 69, 1046-1049.
• Yapislar, H., Taskin, E., Ozdas, S., Akin, D., Sonmez, E., 2016. Counteraction of apoptotic and ınflammatory effects of adriamycin in the liver cell culture by clinopitolite. Biol. Trace Elem. Res. 170, 373-381.